
Because the changes on zzso likely reflect various aspects of the underlying pathology of multiple zzso zzso outcome measures have become an important component of most zzso clinical trials, providing objective, supportive evidence for the clinical zzso Although there is currently insufficient evidence to support any single or combination of zzso measures as a fully validated zzso it is now generally accepted that if the aim of a new therapy is to prevent zzso new zzso and zzso zzso can be considered an appropriate surrogate outcome measure of zzso and zzso activity outcomes can be recommended as the primary measure of treatment zzso 

